XML 33 R23.htm IDEA: XBRL DOCUMENT v3.22.2

Revenue (Tables)

6 Months Ended

Jun. 30, 2022

Revenue From Contract With Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

		Three Months Ended June 30,								Six Months Ended June 30,
		2022				2021				2022				2021
Immune Medicine revenue
Service revenue		$	7,296			$	5,405			$	14,409			$	9,453
Collaboration revenue			15,082				17,634				28,785				33,691
Total Immune Medicine revenue			22,378				23,039				43,194				43,144
MRD revenue
Service revenue			20,282				13,966				35,086				25,303
Regulatory milestone revenue			1,000				1,500				4,000				8,500
Total MRD revenue			21,282				15,466				39,086				33,803
Total revenue		$	43,660			$	38,505			$	82,280			$	76,947

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration